NCT03038152View on ClinicalTrials.gov

Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 11, 2017

Primary Completion Date

March 1, 2021

Study Completion Date

March 1, 2021

Conditions

Breast Carcinoma Metastatic in Lymph NodeStage II Breast Cancer AJCC v6 and v7Stage IIA Breast Cancer AJCC v6 and v7Stage IIB Breast Cancer AJCC v6 and v7Stage IIIA Breast Cancer AJCC v7Stage IIIB Breast Cancer AJCC v7

Interventions

PROCEDURE

Axillary Lymph Node Dissection

Undergo targeted axillary lymph node dissection

PROCEDURE

Localization

Undergo axillary lymph node localization

DEVICE

Medical Device

Receive Magseed via ultrasound guided injection

Trial Locations (1)

77030

M D Anderson Cancer Center, Houston

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT03038152 - Magseed Magnetic Marker in Locating Axillary Lymph Nodes in Patients With Breast Cancer Undergoing Surgery | Biotech Hunter | Biotech Hunter